Today during trading, Eupraxia Pharmaceuticals Inc shares opened at $3.74 and closed at $3.65. Intraday prices ranged from $3.60 to $3.74.

Share prices eased -1.35% from the previous day's close of $3.70.

During the day across North America, the TSX Composite closed -0.73% at 21740.20, the S&P 500 closed -1.20% at 5061.82, the Dow Jones Industrial Average closed -0.65% at 37735.11 and the Nasdaq Composite closed -1.79% at 15885.02.

Eupraxia Pharmaceuticals Inc traded under EPRX on the Toronto Stock Exchange (TSX).

A total of 43,800 shares was traded during the session, with total trades of 83. On average, Eupraxia Pharmaceuticals Inc has traded 63,427 shares over the last 5-days and 56,348 year-to-date.

The TSX overall saw 1,840 price advancers against 3,375 declines and 112 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.60 (April 16,2024). Moreover, the shares have reduced -27.00 percent in 52 weeks, while this year, they have reduced -32.03%.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $131.80 million on a float of 35,623 shares outstanding. Its annual EPS is $-1.53.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Eupraxia Pharmaceuticals Inc is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..